Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Cancer Discovery
|
October 27, 2022
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
Ines Marin, Olga Boix, Andrea Garcia-Garijo, et al.
The Journal of Clinical Investigation
|
March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors
Alena Gros, Paul F Robbins, Xin Yao, et al.
Nature Cancer
|
December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types
Jared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Journal for Immunotherapy of Cancer
|
December 29, 2022
Biomarkers of tumor-reactive CD4<sup>+</sup> and CD8<sup>+</sup> TILs associate with improved prognosis in endometrial cancer
Jara Palomero, Carla Panisello, Maria Lozano-Rabella, et al.
The Journal of Clinical Investigation
|
October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
Alena Gros, Eric Tran, Maria R Parkhurst, et al.
Nature
|
September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil, Suman K Vodnala, David Clever, et al.
Future Oncology (London, England)
|
August 12, 2024
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study
Juan Martin-Liberal, Elena Garralda, Jesús García-Donas, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 7, 2025
Syndecan-3 positively regulates the pro-inflammatory function of macrophages
So Young Lee, Endika Prieto-Fernández, Leire Egia-Mendikute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2023
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
George Coukos, Marco Donia, Brian R Gastman, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Cancer Discovery
|
October 27, 2022
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
Ines Marin, Olga Boix, Andrea Garcia-Garijo, et al.
The Journal of Clinical Investigation
|
March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors
Alena Gros, Paul F Robbins, Xin Yao, et al.
Nature Cancer
|
December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types
Jared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Journal for Immunotherapy of Cancer
|
December 29, 2022
Biomarkers of tumor-reactive CD4<sup>+</sup> and CD8<sup>+</sup> TILs associate with improved prognosis in endometrial cancer
Jara Palomero, Carla Panisello, Maria Lozano-Rabella, et al.
The Journal of Clinical Investigation
|
October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
Alena Gros, Eric Tran, Maria R Parkhurst, et al.
Nature
|
September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil, Suman K Vodnala, David Clever, et al.
Future Oncology (London, England)
|
August 12, 2024
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study
Juan Martin-Liberal, Elena Garralda, Jesús García-Donas, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 7, 2025
Syndecan-3 positively regulates the pro-inflammatory function of macrophages
So Young Lee, Endika Prieto-Fernández, Leire Egia-Mendikute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2023
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
George Coukos, Marco Donia, Brian R Gastman, et al.
Page
of 5